| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 17 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.27M | - | |
| Other | 67.7K | $2.39M | - | |
| CFO | 40.3K | $1.43M | - | |
| Other | 34.6K | $1.22M | - | |
| Dir | 17.8K | $629.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2018 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 2,000 | $78.75 | $157,500.05 | -45.0% | |
| Feb 1, 2018 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 13,000 | $78.75 | $1,023,755.80 | -74.5% | |
| Jan 26, 2018 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 23,572 | $81.09 | $1,911,494.07 | -57.7% | |
| Jan 24, 2018 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 20 | $80.01 | $1,600.20 | -100% | |
| Jan 24, 2018 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 46,408 | $80.01 | $3,713,104.08 | -100% | |
| Jan 23, 2018 | Hoerter Steven L. | Chief Commercial Officer | Sale+OE | 25,000 | $74.83 | $1,870,750.00 | -100% | |
| Jan 23, 2018 | Celgene Corp /de/ | 10% Owner | Buy | 851,154 | $67.00 | $57,027,318.00 | +162.6% | |
| Jan 16, 2018 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 53,000 | $73.16 | $3,877,217.67 | -45.3% | |
| Jan 12, 2018 | Alenson Carman65 | Principal Accounting Officer | Sale+OE | 2,150 | $75.00 | $161,250.00 | -100% | |
| Jan 10, 2018 | Biller Scott | Chief Scientific Officer | Sale+OE | 3,000 | $65.00 | $195,000.00 | -5.4% |